Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Cell Cycle ; 16(21): 2128-2138, 2017.
Article in English | MEDLINE | ID: mdl-28933990

ABSTRACT

Most studies on new cancer drugs are based on population-derived data, where the absence of response of a small population may pass unnoticed. Thus, individual longitudinal tracking of cells is important for the future development of efficient cancer treatments. We have used digital holographic microscopy to track individual JIMT-1 human breast cancer cells and L929 mouse fibroblast cultivated in normoxia or hypoxia. In addition, JIMT-1 cells were treated with salinomycin, a cancer stem cell targeting compound. Three-day time-lapse movies were captured and individual cells were analysed with respect to cell division (cell cycle length) and cell movement. Comparing population-doubling time derived from population-based growth curves and individual cell cycle time data from time-lapse movies show that the former hide a sub-population of dividing cells. Salinomycin treatment increased the motility of cells, however, this motility did not result in an increased distant migration i.e. the cells increased their local movement. MCF-7 breast cancer cells showed similar motility behaviour as salinomycin-treated JIMT-1 cells. We suggest that combining features, such as motility and migration, can be used to distinguish cancer cells with mesenchymal (JIMT-1) and epithelial (MCF-7) features. The data clearly emphasize the importance of longitudinal cell tracking to understand the biology of individual cells under different conditions.


Subject(s)
Cell Division/drug effects , Cell Movement/drug effects , Hypoxia/metabolism , Neoplastic Stem Cells/drug effects , Pyrans/pharmacology , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Cell Line, Tumor , Cell Movement/physiology , Cell Proliferation/drug effects , Female , Humans , Neoplastic Stem Cells/metabolism
2.
Cytometry A ; 91(5): 460-469, 2017 05.
Article in English | MEDLINE | ID: mdl-28437571

ABSTRACT

Cell proliferation assays are widely applied in biological sciences to understand the effect of drugs over time. However, current methods often assess cell population growth indirectly, that is, the cells are not actually counted. Instead other parameters, for example, the amount of protein, are determined. These methods often also demand phototoxic labels, have low temporal resolution, or employ end-point assays, and frequently are labor intensive. We have developed a robust and label-free kinetic cell proliferation assay with high temporal resolution for adherent cells using digital holographic microscopy (DHM), one of many quantitative phase microscopy techniques. As no labels or stains are required, and only very low intensity illumination is necessary, the technique allows for noninvasive continuous cell counting. Only two image processing settings were adjusted between cell lines, making the assay practical, user friendly, and free of user bias. The developed direct assay was validated by analyzing cell cultures treated with various concentrations of the anti-cancer drug etoposide, a well-established topoisomerase inhibitor that causes DNA damage and leads to programmed cell death. After treatment, the unstained adherent cells were nondestructively imaged every 30 min for 36 h inside a cell incubator. In the recorded time-lapse image sequences, individual cells were automatically identified to provide detailed growth curves and growth rate data of cell number, confluence, and average cell volume. Our results demonstrate how these parameters facilitate a deeper understanding of cell processes than what is achievable with current single-parameter and end-point methods. © 2017 International Society for Advancement of Cytometry.


Subject(s)
Cell Count/methods , Holography/methods , Image Processing, Computer-Assisted/methods , Microscopy/methods , Cell Line , Cell Proliferation/genetics , Humans
3.
Amino Acids ; 42(2-3): 929-37, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21809081

ABSTRACT

The retinoblastoma protein (pRb) pathway is frequently altered in breast cancer cells. pRb is involved in the regulation of cell proliferation and cell death. The breast cancer cell line L56Br-C1 does not express pRb and is extremely sensitive to treatment with the polyamine analogue N(1),N(11)-diethylnorspermine (DENSPM) which causes apoptosis. Polyamines are essential for the regulation of cell proliferation, cell differentiation and cell death. DENSPM depletes cells of polyamines, e.g., by inducing the activity of the polyamine catabolic enzyme spermidine/spermine N(1)-acetyltransferase (SSAT). In this study, L56Br-C1 cells were transfected with human pRb-cDNA. Overexpression of pRb inhibited DENSPM-induced cell death and DENSPM-induced SSAT activity. This suggests that the pRb protein level is a promising marker for polyamine depletion sensitivity and that there is a connection between pRb and the regulation of SSAT activity. We also show that SSAT protein levels and SSAT activity do not always correlate, suggesting that there is an unknown regulation of SSAT.


Subject(s)
Apoptosis/physiology , Polyamines/toxicity , Retinoblastoma Protein/physiology , Acetyltransferases/metabolism , Cell Line, Tumor , Female , Flow Cytometry , Humans
4.
Anticancer Drugs ; 21(10): 917-26, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20729713

ABSTRACT

Neuroblastoma is a highly malignant neoplasm found in young children. Although children with high-risk neuroblastoma respond to chemotherapy, relapses are common. On account of poor treatment outcome, new treatment strategies are constantly sought for neuroblastoma. Polyamine analogues are potentially novel substances for treatment of neuroblastoma. In this study, we have treated two neuroblastoma cell lines, SH-SY5Y and LA-N-1, with the spermine analogue N1, N11-Diethylnorspermine (DENSPM). SH-SY5Y was the most sensitive cell line, in which DENSPM treatment resulted in an inhibition of cell proliferation and an induction of cell death. The cell death induced by DENSPM treatment was apoptotic, as evidenced by cleavage of procaspase 3 and induction of caspase-3 activity. In contrast, DENSPM treatment only resulted in a slight inhibition of cell proliferation in LA-N-1 cells. There were several possible causes for the lower sensitivity to DENSPM treatment in the latter cell line when compared with SH-SY5Y cells. DENSPM-induced polyamine depletion was more extensive in SH-SY5Y cells than in LA-N-1 cells. This was partly because of a higher induction of the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase in the cell line SH-SY5Y. The DENSPM-induced polyamine depletion was also caused by the inhibition of ornithine decarboxylase. LA-N-1 cells contained a higher level of the prosurvival protein survivin, which was further increased after DENSPM treatment. In contrast, DENSPM treatment resulted in a decreased survivin level in SH-SY5Y cells.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Neuroblastoma/therapy , Spermine/analogs & derivatives , Acetyltransferases/antagonists & inhibitors , Acetyltransferases/metabolism , Caspase 3/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Child , Culture Media , Dose-Response Relationship, Drug , Humans , Inhibitor of Apoptosis Proteins , Microtubule-Associated Proteins/metabolism , Neuroblastoma/metabolism , Neuroblastoma/pathology , Ornithine Decarboxylase/metabolism , Ornithine Decarboxylase Inhibitors , Spermine/pharmacology , Survivin
5.
Exp Cell Res ; 316(5): 688-94, 2010 Mar 10.
Article in English | MEDLINE | ID: mdl-20036232

ABSTRACT

The phenomenon of contact guidance on thin fibers has been known since the beginning of the 20th century when Harrison studied cells growing on fibers from spider's web. Since then many studies have been performed on structured surfaces and fibers. Here we present a new way to induce guidance of cells or cell processes using magnetic nanowires. We have manufactured magnetic Ni-nanowires (200 nm in diameter and 40 microm long) with a template-based electro-deposition method. Drops of a nanowire/ethanol suspension were placed on glass cover slips. The nanowires were aligned in an external magnetic field and adhered to the cover slips after evaporation of the ethanol. When the wires had adhered, the magnetic field was removed. L929 fibroblasts and dissociated dorsal root ganglia (DRG) neurons from mice were cultured on the nanowire-coated cover slips for 24 h and 72 h respectively. The fibroblasts were affected by the aligned nanowires and displayed contact guidance. Regenerated axons also displayed contact guidance on the wires. There were no overt signs of toxicity caused by Ni-wires. Aligned magnetic nanowires can be useful for lab-on-a-chip devices and medical nerve grafts.


Subject(s)
Cell Movement/physiology , Magnetics , Nanowires , Animals , Cells, Cultured , Fibroblasts/cytology , Fibroblasts/physiology , Ganglia, Spinal/cytology , Guided Tissue Regeneration/methods , Lab-On-A-Chip Devices , Mice , Nanotechnology/instrumentation , Nanotechnology/methods , Nanowires/chemistry , Nerve Regeneration/physiology , Neurons/cytology , Neurons/physiology , Nickel/chemistry , Surface Properties
6.
J Proteome Res ; 8(11): 5008-19, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19785415

ABSTRACT

Hormone-sensitive lipase (HSL), a key enzyme in fatty acid mobilization from lipid stores, is expressed in the liver and decreased hepatic insulin sensitivity has been reported in our HSL null mouse model. Here, an integrated approach, comprising transcriptomics and proteomics together with targeted metabolite analysis, was used to investigate the liver phenotype of HSL null mice. Oligonucleotide microarray analysis revealed altered expression of genes involved in lipid and polyamine metabolism in HSL null mice compared with wild-type mice and in genes controlling the immune system in mice on high-fat diet versus mice on normal diet. Two-dimensional gel electrophoresis followed by MS and/or MS/MS allowed identification of 52 and 22 unique proteins differentially regulated according to the genotype and diet, respectively. Changes were observed mainly for proteins related to metabolism, including several proteins involved in polyamine metabolism or exhibiting methyl transferase activity. Despite the coordinated changes in mRNA and protein levels in polyamine pathways, no significant differences in levels of key polyamine metabolites were detected between the two genotypes. This study identifies a link between HSL and polyamine metabolism, which deserves further attention in view of the emerging data suggesting that disturbances in polyamine metabolism may affect insulin sensitivity. The present work also describes a limited correlation between mRNA, protein and metabolite levels, thus, underscoring the importance of integrated approaches.


Subject(s)
Lipid Metabolism , Polyamines/metabolism , Sterol Esterase/metabolism , Animals , Diet , Dietary Fats/metabolism , Electrophoresis, Gel, Two-Dimensional/methods , Fatty Acids/metabolism , Mass Spectrometry/methods , Mice , Mice, Knockout , Microarray Analysis , Molecular Sequence Data , Sterol Esterase/genetics
7.
Anticancer Drugs ; 20(4): 230-7, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19288605

ABSTRACT

A number of polyamine analogs are currently used in various clinical trials as cancer treatment and it is important to investigate their effects not only on cancer cells but also on normal cells. Treatment with polyamine analogs depletes cells of polyamines and inhibits cell proliferation, but the analogs cannot take over the normal function of the natural polyamines in the cell. In this study, the normal-like breast epithelial cell line MCF-10A was treated with the polyamine analog N',N"-diethylnorspermine (DENSPM). The cells were then studied using a bromodeoxyuridine- DNA flow cytometry method as well as western blot. The ability of both normal-like and breast cancer cells to recover from DENSPM treatment was also studied. DENSPM treatment of MCF-10A cells resulted in a prolongation of the S and G2 +M phases, followed by a G1/S block. The p53/p21/RB1 pathway was involved in the G1/S block as shown by increased levels of p53 and p21 detected by western blot. Decreased levels of cyclin E1, cyclin A2, and cyclin B1 in DENSPM-treated cells can explain the prolongation of cell cycle phases that occurred before the G1/S block. We also show that MCF-10A cells rapidly recover from DENSPM-induced growth inhibition in contrast to four human breast cancer cell lines. The goal of cancer treatment is to cause minimal and reversible damage to normal cells, while cancer cells should be eliminated. Altogether, the data show that treatment with polyamine analogs spares normal cells, while negatively affecting the cancer cells.


Subject(s)
Antineoplastic Agents/pharmacology , Breast Neoplasms/drug therapy , Cell Cycle/drug effects , Spermine/analogs & derivatives , Blotting, Western , Breast Neoplasms/pathology , Bromodeoxyuridine , Cell Line , Cell Line, Tumor , Cyclin A/drug effects , Cyclin A/metabolism , Cyclin A2 , Cyclin B/drug effects , Cyclin B/metabolism , Cyclin B1 , Cyclin E/drug effects , Cyclin E/metabolism , DNA , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Female , Flow Cytometry , Humans , Oncogene Proteins/drug effects , Oncogene Proteins/metabolism , Spermine/pharmacology
8.
Essays Biochem ; 46: 63-76, 2009 Nov 04.
Article in English | MEDLINE | ID: mdl-20095970

ABSTRACT

Cell-cycle progression is a one-way journey where the cell grows in size to be able to divide into two equally sized daughter cells. The cell cycle is divided into distinct consecutive phases defined as G(1) (first gap), S (synthesis), G(2) (second gap) and M (mitosis). A non-proliferating cell, which has retained the ability to enter the cell cycle when it receives appropriate signals, is in G(0) phase, and cycling cells that do not receive proper signals leave the cell cycle from G(1) into G(0). One of the major events of the cell cycle is the duplication of DNA during S-phase. A group of molecules that are important for proper cell-cycle progression is the polyamines. Polyamine biosynthesis occurs cyclically during the cell cycle with peaks in activity in conjunction with the G(1)/S transition and at the end of S-phase and during G(2)-phase. The negative regulator of polyamine biosynthesis, antizyme, shows an inverse activity compared with the polyamine biosynthetic activity. The levels of the polyamines, putrescine, spermidine and spermine, double during the cell cycle and show a certain degree of cyclic variation in accordance with the biosynthetic activity. When cells in G(0)/G(1) -phase are seeded in the presence of compounds that prevent the cell-cycle-related increases in the polyamine pools, the S-phase of the first cell cycle is prolonged, whereas the other phases are initially unaffected. The results point to an important role for polyamines with regard to the ability of the cell to attain optimal rates of DNA replication.


Subject(s)
Polyamines/metabolism , Animals , Cell Cycle/drug effects , Cyclins/metabolism , DNA Replication , Gene Expression Regulation , Humans , Models, Biological
9.
Cell Biol Int ; 32(12): 1467-77, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18786645

ABSTRACT

Polyamine depletion causes S phase prolongation, and earlier studies indicate that the elongation step of DNA replication is affected. This led us to investigate the effects of polyamine depletion on enzymes crucial for Okazaki fragment maturation in the two breast cancer cell lines MCF-7 and L56Br-C1. In MCF-7 cells, treatment with N(1),N(11)-diethylnorspermine (DENSPM) causes S phase prolongation. In L56Br-C1 cells the prolongation is followed by massive apoptosis. In the present study we show that L56Br-C1 cells have substantially lower basal expressions of two Okazaki fragment maturation key proteins, DNA ligase I and FEN1, than MCF-7 cells. Thus, these two proteins might be promising markers for prediction of polyamine depletion sensitivity, something that can be useful for cancer treatment with polyamine analogues. DENSPM treatment affects the cellular distribution of FEN1 in L56Br-C1 cells, but not in MCF-7 cells, implying that FEN1 is affected by or involved in DENSPM-induced apoptosis.


Subject(s)
DNA Ligases/metabolism , DNA Replication/genetics , DNA/metabolism , Flap Endonucleases/metabolism , Polyamines/metabolism , S Phase/genetics , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Apoptosis/genetics , Biomarkers, Tumor/analysis , Biomarkers, Tumor/metabolism , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Carcinoma/drug therapy , Carcinoma/genetics , Carcinoma/metabolism , Cell Line, Tumor , DNA Ligase ATP , Drug Resistance, Neoplasm/drug effects , Drug Resistance, Neoplasm/genetics , Humans , Polyamines/agonists , Spermine/analogs & derivatives , Spermine/pharmacology , Spermine/therapeutic use
10.
DNA Cell Biol ; 27(9): 511-6, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18554080

ABSTRACT

It is well known that the positively charged polyamines have a DNA-stabilizing function and that polyamine depletion alters chromatin function. We have previously shown that polyamine depletion causes an S phase prolongation, and others have shown that there is an accumulation of Okazaki-like fragments in polyamine-depleted cells. In the present study, we have used the comet assay to investigate polyamine depletion-induced DNA strand breaks. Three breast cancer cell lines and one normal-like breast cell line were treated with the polyamine analogue N(1),N(11)-diethylnorspermine or with the polyamine biosynthesis inhibitor 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664). The comet assay showed that polyamine depletion resulted in DNA strand breaks. We also show that these DNA strand breaks occurred in cells where there was no expression of gamma-H2AX, which is a marker of DNA double-strand breaks. Thus, our conclusion is that polyamine depletion causes DNA single-strand breaks, which may be the cause for the observed delay in S phase progression.


Subject(s)
DNA Damage/drug effects , Polyamines/metabolism , Amidines/pharmacology , Cell Cycle , Cell Line , Cell Line, Tumor , Comet Assay , Histones/metabolism , Humans , Indans/pharmacology , Spermine/analogs & derivatives , Spermine/pharmacology
11.
Anticancer Drugs ; 19(4): 359-68, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18454046

ABSTRACT

Polyamine analogues are presently undergoing clinical evaluation in the treatment of cancer. To better understand under what circumstances treatment with a polyamine analogue will yield beneficial results, we have investigated the effect of N,N-diethylnorspermine (DENSPM) on cell cycle kinetics of the human breast cancer cell lines SK-BR-3, MCF-7, HCC1937, and L56Br-C1. A bromodeoxyuridine-DNA flow cytometry method was used to evaluate the treatment with 10 micromol/l DENSPM on cell cycle kinetics. A correlation between polyamine pool size after DENSPM treatment and cell cycle kinetic effects was found. The most sensitive cell cycle phase was the S phase, followed by an effect on the G2+M phase and then the G1/S transition. The levels of a number of cell cycle regulatory proteins such as cyclin E1, cyclin A2, and cyclin B1 were lowered by DENSPM treatment, which may explain the effects on cell cycle kinetics. The two cell lines that were most sensitive to DENSPM treatment belong to the basal-like subtype of breast cancer and they were deficient with respect to p53, BRCA1, and RB1.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Cycle/drug effects , Polyamines/pharmacology , Spermine/analogs & derivatives , Blotting, Western , Breast Neoplasms , Bromodeoxyuridine/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Cyclins/metabolism , Female , Flow Cytometry , Humans , Microscopy, Fluorescence , Spermine/pharmacology
12.
Cell Biol Int ; 32(1): 66-74, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17920946

ABSTRACT

The spermine analogue N(1),N(11)-diethylnorspermine (DENSPM) efficiently depletes the polyamine pools in the breast cancer cell line L56Br-C1 and induces apoptotic cell death via the mitochondrial pathway. In this study, we have over-expressed the anti-apoptotic protein Bcl-2 in L56Br-C1 cells and investigated the effect of DENSPM treatment. DENSPM-induced cell death was significantly reduced in Bcl-2 over-expressing cells. Bcl-2 over-expression reduced DENSPM-induced release of the pro-apoptotic proteins AIF, cytochrome c, and Smac/DIABLO from the mitochondria. Bcl-2 over-expression reduced the DENSPM-induced activation of caspase-3. Bcl-2 over-expression also prevented DENSPM-induced Bax cleavage and reduction of Bcl-X(L) and survivin levels. The DENSPM-induced activation of the polyamine catabolic enzyme spermidine/spermine N(1)-acetyltransferase was reduced by Bcl-2 over-expression, partly preventing polyamine depletion. Thus, Bcl-2 over-expression prevented a number of DENSPM-induced apoptotic effects.


Subject(s)
Apoptosis/drug effects , Breast Neoplasms/metabolism , Proto-Oncogene Proteins c-bcl-2/physiology , Spermine/analogs & derivatives , Acetyltransferases/metabolism , Apoptosis Inducing Factor/metabolism , Apoptosis Regulatory Proteins/metabolism , Caspase 3/metabolism , Cell Line, Tumor , Cytochromes c/metabolism , Gene Expression Regulation, Neoplastic , Humans , Inhibitor of Apoptosis Proteins , Intracellular Signaling Peptides and Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Mitochondrial Proteins/metabolism , Neoplasm Proteins/metabolism , Polyamines/metabolism , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Spermine/pharmacology , Survivin , Transfection , bcl-2-Associated X Protein/metabolism
13.
Bioorg Med Chem ; 15(23): 7426-33, 2007 Dec 01.
Article in English | MEDLINE | ID: mdl-17869123

ABSTRACT

We here report the synthesis of the two polyamine-based nucleoside derivatives 5-{[bis-(3-aminopropyl)amino]acetamido-1-propynyl}uridine and 2-{[bis-(3-aminopropyl)amino]-acetamido-1-propynyl}adenosine. The various polyamine derivatives have been used in thermal melting analysis using DNA from herring testes, and in cellular studies using four different cell lines. The compounds were all found to be non-toxic, thus holding good promise for future use as siRNA building blocks.


Subject(s)
Adenosine/analogs & derivatives , Adenosine/chemical synthesis , Adenosine/pharmacology , Breast Neoplasms/drug therapy , DNA/drug effects , Polyamines/chemistry , Uridine/analogs & derivatives , Uridine/chemical synthesis , Uridine/pharmacology , Binding Sites , Cell Line, Tumor , Cell Proliferation/drug effects , Circular Dichroism/methods , DNA/chemistry , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , In Vitro Techniques , Molecular Structure , Structure-Activity Relationship , Temperature , Tumor Cells, Cultured
14.
Exp Cell Res ; 308(2): 254-64, 2005 Aug 15.
Article in English | MEDLINE | ID: mdl-15923003

ABSTRACT

Polyamines are organic cations, which are considered essential for normal cell cycle progression. This view is based on results from numerous studies using a variety of enzyme inhibitors or polyamine analogues interfering with either the metabolism or the physiological functions of the polyamines. However, the presence of non-specific effects may be hard to rule out in such studies. In the present study, we have for the first time used a transgenic cell system to analyze the importance of polyamines in cell growth. We have earlier shown that expression of trypanosomal ODC in an ODC-deficient variant of CHO cells (C55.7) supported growth of these otherwise polyamine auxotrophic cells. However, one of the transgenic cell lines grew much slower than the others. As shown in the present study, the level of ODC activity was much lower in these cells, and that was reflected in a reduction of cellular polyamine levels. Analysis of cell cycle kinetics revealed that reduction of growth was correlated to prolongation of the G1, S, and G2+M phases in the cells. Providing exogenous putrescine to the cells resulted in a normalization of polyamine levels as well as cell cycle kinetics indicating a causal relationship.


Subject(s)
Cell Cycle Proteins/metabolism , Cell Cycle/physiology , Ornithine Decarboxylase/metabolism , Polyamines/metabolism , Animals , CHO Cells , Cell Cycle/drug effects , Cell Division/drug effects , Cell Division/physiology , Cell Proliferation , Cricetinae , DNA/metabolism , G1 Phase/drug effects , G1 Phase/physiology , G2 Phase/drug effects , G2 Phase/physiology , Kinetics , Ornithine Decarboxylase/pharmacology , Polyamines/pharmacology , Putrescine/metabolism , Putrescine/pharmacology , S Phase/drug effects , S Phase/physiology , Time Factors , Transfection , Transgenes/physiology
15.
Cancer Res ; 63(13): 3619-25, 2003 Jul 01.
Article in English | MEDLINE | ID: mdl-12839950

ABSTRACT

The clinically relevant polyamine analogue N(1),N(11)-diethylnorspermine (DENSPM) inhibits cell growth by down-regulating polyamine biosynthesis, up-regulating polyamine catabolism at the level of spermidine/spermine N(1)-acetyltransferase (SSAT), and depleting intracellular polyamine pools. Among human melanoma cell lines, the analogue causes rapid apoptosis in SK-MEL-28 cells and a sharp G(1) arrest in MALME-3M cells. This study reveals that DENSPM potently activates the mitogen-activated protein kinase (MAPK) pathways in melanoma cells and investigates the role of this response in determining cellular outcomes. Onset of apoptosis was preceded by an intense phosphorylation of the MAPKs, including extracellular signal-regulated kinase 1/2, c-Jun NH(2)-terminal kinase, and p38 in both SK-MEL-28 and MALME-3M cells. A panel of DENSPM analogues differing only in their ability to induce SSAT was used to show that MAPK activation was causally linked to induction of SSAT activity and related oxidative events. The latter was confirmed with the polyamine oxidase inhibitor MDL-75275 and the antioxidant N-acetyl-L-cysteine, which when used in combination with DENSPM, decreased MAPK activation and as previously shown, reduced apoptosis. The MAP/extracellular signal-regulated kinase-1 inhibitor PD 98059 reduced activation of all three kinases but failed to alter apoptosis in DENSPM-treated SK-MEL-28 cells. By contrast, the inhibitor prevented p21(waf1/cip1) induction and enhanced apoptosis in MALME-3M cells as indicated by accelerated caspase-3 activation and positive annexin V staining. The generality of this effect was demonstrated in DENSPM-treated A375 and LOX human melanoma cells. Taken together, the importance of the MAPK pathways in determining the biological response to DENSPM treatment is dependent on the genetic environment of the cell.


Subject(s)
Antineoplastic Agents/toxicity , Melanoma/pathology , Mitogen-Activated Protein Kinases/metabolism , Polyamines/metabolism , Spermine/analogs & derivatives , Spermine/toxicity , Apoptosis/drug effects , Enzyme Activation , Flavonoids/pharmacology , Humans , Kinetics , Oligonucleotide Array Sequence Analysis , Phosphorylation , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...